SCHEMBL3784669

SCHEMBL3784669

CCCOc1cc(Cl)ccc1N

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.51
KDM4E B2RXH2 3/20 0.51
ALDH1A1 P00352 3/20 0.51
KMT2A Q03164 3/20 0.51
MEN1 O00255 2/20 0.51
POLB P06746 2/20 0.51
USP2 O75604 1/20 0.51
TP53 P04637 1/20 0.51
GAA P10253 1/20 0.51
CASP1 P29466 1/20 0.51
HTT P42858 1/20 0.51
CASP7 P55210 1/20 0.51
ATM Q13315 1/20 0.51
HTR2C P28335 2/20 0.48
HTR2B P41595 2/20 0.48
CSNK2A1 P68400 2/20 0.47
L3MBTL1 Q9Y468 2/20 0.47
HPGD P15428 1/20 0.47
MAPK1 P28482 1/20 0.47
HSD17B10 Q99714 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3785269 0.91 CYP1A2 (0.58) MAPTKDM4EALDH1A1KMT2AMEN1
SCHEMBL29684233 0.89 CYP1A2 (0.51) MAPTKDM4EALDH1A1KMT2AMEN1
SCHEMBL363534 0.85 MAPT (0.66) MAPTKDM4EALDH1A1KMT2AMEN1
SCHEMBL315662 0.85 ALDH1A1 (0.66) MAPTKDM4EALDH1A1KMT2AMEN1
SCHEMBL29684472 0.84 HTR2C (0.49) MAPTKDM4EALDH1A1KMT2AMEN1
SCHEMBL15716191 0.84 HTR2C (0.49) MAPTKDM4EALDH1A1KMT2AMEN1
SCHEMBL3781671 0.82 MAPT (0.54) MAPTKDM4EALDH1A1KMT2AMEN1
SCHEMBL8263900 0.82 LMNA (0.48) MAPTKDM4EALDH1A1KMT2AMEN1
SCHEMBL5094816 0.81 ALDH1A1 (0.47) MAPTKDM4EALDH1A1KMT2AMEN1
SCHEMBL30433987 0.81 GAA (0.70) MAPTKDM4EALDH1A1KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND SUMITOMO CHEMICAL COMPANY LIMITED (JP) 2010-04-08 US disclosed
EP-1914221-A1 PROCESS FOR PRODUCING BIARYL COMPOUND Sumitomo Chemical Company, Limited (JP) 2008-04-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND NISCH, BLVRB, BBOX1 MAPT 3312/4885KDM4E 2606/4885ALDH1A1 4339/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.